Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Suicide and deliberate self-harm in Pakistan: a scoping review.

Shekhani SS, Perveen S, Hashmi DE, Akbar K, Bachani S, Khan MM.

BMC Psychiatry. 2018 Feb 12;18(1):44. doi: 10.1186/s12888-017-1586-6. Review.

2.

Induced Superaerophobicity onto a Non-superaerophobic Catalytic Surface for Enhanced Hydrogen Evolution Reaction.

Akbar K, Hussain S, Truong L, Roy SB, Jeon JH, Jerng SK, Kim M, Yi Y, Jung J, Chun SH.

ACS Appl Mater Interfaces. 2017 Dec 20;9(50):43674-43680. doi: 10.1021/acsami.7b13918. Epub 2017 Dec 7.

PMID:
29179532
3.

HIV Diagnosis and Treatment through Advanced Technologies.

Zulfiqar HF, Javed A, Sumbal, Afroze B, Ali Q, Akbar K, Nadeem T, Rana MA, Nazar ZA, Nasir IA, Husnain T.

Front Public Health. 2017 Mar 7;5:32. doi: 10.3389/fpubh.2017.00032. eCollection 2017. Review.

4.

The impact of postpartum hemoglobin levels on maternal quality of life after delivery: a prospective exploratory study.

Miller CM, Ramachandran B, Akbar K, Carvalho B, Butwick AJ.

Ann Hematol. 2016 Dec;95(12):2049-2055. Epub 2016 Sep 13.

5.

Hydrophobic Surface Treatment and Interrupted Atomic Layer Deposition for Highly Resistive Al2O3 Films on Graphene.

Jeon JH, Jerng SK, Akbar K, Chun SH.

ACS Appl Mater Interfaces. 2016 Nov 2;8(43):29637-29641. Epub 2016 Oct 24.

PMID:
27735182
6.

Knowledge of blood loss at delivery among postpartum patients.

Farber MK, Miller CM, Ramachandran B, Hegde P, Akbar K, Goodnough LT, Butwick AJ.

PeerJ. 2016 Aug 31;4:e2361. doi: 10.7717/peerj.2361. eCollection 2016.

7.

Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features.

Akbar M, Akbar K, Naveed D.

J Ayub Med Coll Abbottabad. 2014 Jul-Sep;26(3):290-3.

PMID:
25671929
8.

Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.

Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF; Diabetes Prevention Program Research Group.

Diabet Med. 2014 Sep;31(9):1064-8. doi: 10.1111/dme.12437. Epub 2014 Apr 9.

9.

Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.

Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ; Diabetes Prevention Program Research Group.

Diabetologia. 2014 May;57(5):935-9. doi: 10.1007/s00125-014-3183-2. Epub 2014 Feb 20.

10.

Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence.

Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL; Diabetes Prevention Program Research Group.

Int J Behav Nutr Phys Act. 2014 Feb 12;11:16. doi: 10.1186/1479-5868-11-16.

11.

Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.

Franks PW, Christophi CA, Jablonski KA, Billings LK, Delahanty LM, Horton ES, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2014 Mar;57(3):485-90. doi: 10.1007/s00125-013-3133-4. Epub 2013 Dec 7.

12.

Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.

Christophi CA, Resnick HE, Ratner RE, Temprosa M, Fowler S, Knowler WC, Shamoon H, Barrett-Connor E, Kahn SE; Diabetes Prevention Program Research Group.

J Diabetes Complications. 2013 Mar-Apr;27(2):150-7. doi: 10.1016/j.jdiacomp.2012.09.012. Epub 2012 Nov 7.

13.

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC; Diabetes Prevention Program Research Group.

PLoS One. 2012;7(9):e44424. doi: 10.1371/journal.pone.0044424. Epub 2012 Sep 11.

14.

Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.

Pollin TI, Isakova T, Jablonski KA, de Bakker PI, Taylor A, McAteer J, Pan Q, Horton ES, Delahanty LM, Altshuler D, Shuldiner AR, Goldberg RB, Florez JC, Franks PW; Diabetes Prevention Program Research Group.

PLoS Genet. 2012;8(8):e1002895. Epub 2012 Aug 30.

15.

Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.

Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW; Diabetes Prevention Program Research Group.

Diabetes Care. 2012 Feb;35(2):363-6. doi: 10.2337/dc11-1328. Epub 2011 Dec 16.

16.

TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program.

McCaffery JM, Jablonski KA, Franks PW, Dagogo-Jack S, Wing RR, Knowler WC, Delahanty L, Dabelea D, Hamman R, Shuldiner AR, Florez JC; Diabetes Prevention Program Research Group.

PLoS One. 2011;6(7):e21518. doi: 10.1371/journal.pone.0021518. Epub 2011 Jul 26.

17.

Menopause and risk of diabetes in the Diabetes Prevention Program.

Kim C, Edelstein SL, Crandall JP, Dabelea D, Kitabchi AE, Hamman RF, Montez MG, Perreault L, Foulkes MA, Barrett-Connor E; Diabetes Prevention Program Research Group.

Menopause. 2011 Aug;18(8):857-68. doi: 10.1097/gme.0b013e31820f62d0.

18.

More than just skin deep? Personality information influences men's ratings of the attractiveness of women's body sizes.

Swami V, Furnham A, Chamorro-Premuzic T, Akbar K, Gordon N, Harris T, Finch J, Tovée MJ.

J Soc Psychol. 2010 Nov-Dec;150(6):628-47. doi: 10.1080/00224540903365497.

PMID:
21166328
19.

Surgical management of tuberculous small bowel obstruction.

Akbar M, Fakhar-ul-Islam, Haider IZ, Naveed D, Akbar I, Khattak I, Akbar K, Zafar A.

J Ayub Med Coll Abbottabad. 2010 Apr-Jun;22(2):171-5.

PMID:
21702296
20.

First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes.

Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SL, Hamman RF, Hoskin MA, Knowler WC, Ma Y; Diabetes Prevention Program Research Group.

Int J Obes (Lond). 2008 Oct;32(10):1537-44. doi: 10.1038/ijo.2008.134. Epub 2008 Aug 19. Erratum in: Int J Obes (Lond). 2009 Jan;33(1):182.

Supplemental Content

Loading ...
Support Center